Prosight Management »

Phreesia shares owned by Prosight Management

Quarter-by-quarter ownership of Phreesia (PHR) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Phreesia

Tip: Access up to 7 years of quarterly data

All positions including Phreesia held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phreesia by Prosight Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.2M 1.1M 8.38
2025-12-31 $17M 977k 16.92

More positions owned by Prosight Management

Nektar Therapeutics Com New (NKTR)
Boston Scientific Corporation (BSX)
Janux Therapeutics (JANX)
Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Genedx Holdings Corp Com Cl A (WGS)
Shattuck Labs (STTK)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Alnylam Pharmaceuticals (ALNY)
Meiragtx Holdings (MGTX)
Alkermes SHS (ALKS)
Syndax Pharmaceuticals (SNDX)
Veeva Sys Cl A Com (VEEV)
Zymeworks Del (ZYME)

View all positions for Prosight Management

Top funds holding Phreesia

Pale Fire Capital SE
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
AQR Capital Management
State Street Corporation
Algert Coldiron Investors
Geode Capital Management
Prosight Management
Jacobs Levy Equity Management
Goldman Sachs Group
Acadian Asset Management
Jennifer Ranahan
American Century Companies
Nuveen

View all funds holding Phreesia